At the end of the 6-month intervention , HbA1c was similarly reduced in both the glargine ( from 11.811.70 % to 6.480.79 % ; P < 0.001 ) and OAD ( from 11.711.89 % to 6.160.52 % ; P < 0.001 ) groups .